Stay updated on Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-13T03:47:18.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the page. A large portion of the Study Documents and related metadata, including document names, contributors, and source information, was removed from the listing.
    Difference
    18%
    Check dated 2026-09-21T22:46:41.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The study details page history shows a new revision entry v3.6.6 added and the prior revision v3.6.5 removed. This indicates a minor update to the page metadata rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-08-31T17:12:38.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a new version of the page documentation. This update changes only the version tag and does not modify the study details shown on the page.
    Difference
    0.1%
    Check dated 2026-08-10T09:56:38.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The Study Protocol and Statistical Analysis Plan document revision was updated from v3.6.3 to v3.6.4, indicating a newer version is now available.
    Difference
    0.1%
    Check dated 2026-07-26T18:57:05.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.2 to v3.6.3, indicating a small update to the document or template rather than a change to trial information.
    Difference
    0.1%
    Check dated 2026-07-05T04:46:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.